Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, pegylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volumeJAYSON, G. C; PARKER, G. J. M; BUCKLEY, D. L et al.Journal of clinical oncology. 2005, Vol 23, Num 5, pp 973-981, issn 0732-183X, 9 p.Article

Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotypeGALIMBERTI, Sara; FERRERI, Maria I; SIMI, Paolo et al.British journal of haematology. 2009, Vol 147, Num 5, pp 763-766, issn 0007-1048, 4 p.Article

NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorderVIZMANOS, José L; NOVO, Francisco J; ROMAN, José P et al.Cancer research (Baltimore). 2004, Vol 64, Num 8, pp 2673-2676, issn 0008-5472, 4 p.Article

Imatinib mesylate in chordomaCASALI, Paolo G; MESSINA, Antonella; BERTULLI, Rossella et al.Cancer. 2004, Vol 101, Num 9, pp 2086-2097, issn 0008-543X, 12 p.Article

Genetic association between 5'-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean populationKIM, Hak-Jae; KIM, Min-Ho; YUNHEE KIM KWON et al.Schizophrenia research. 2008, Vol 103, Num 1-3, pp 201-208, issn 0920-9964, 8 p.Article

Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β geneWALZ, Christoph; METZGEROTH, Georgia; CROSS, Nicholas C. P et al.Haematologica (Roma). 2007, Vol 92, Num 2, pp 163-169, issn 0390-6078, 7 p.Article

KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)LEVINE, R. L; WADLEIGH, M; STERNBERG, D. W et al.Leukemia. 2005, Vol 19, Num 1, pp 27-30, issn 0887-6924, 4 p.Article

A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisoloneWANG, J. R.-Y; YEN, C. -C; GAU, J. -P et al.Journal of clinical pharmacy and therapeutics (Print). 2010, Vol 35, Num 6, pp 733-736, issn 0269-4727, 4 p.Article

Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusionLAHORTIGA, Idoya; AKIN, Cem; LESSIN, Lawrence S et al.Haematologica (Roma). 2008, Vol 93, Num 1, pp 49-56, issn 0390-6078, 8 p.Article

Complete remission of TEL-PDGFRB-induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657CAIN, Jennifer A; GRISOLANO, Jay L; LAIRD, A. Douglas et al.Blood. 2004, Vol 104, Num 2, pp 561-564, issn 0006-4971, 4 p.Article

Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsHIDALGO-CURTIS, Claire; APPERLEY, Jane F; STARK, Anthony et al.British journal of haematology. 2010, Vol 148, Num 2, pp 268-273, issn 0007-1048, 6 p.Article

Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinibWILKINSON, Kathryn; VELLOSO, Elvira R. P; LOPES, Luiz Fernando et al.Blood. 2003, Vol 102, Num 12, pp 4187-4190, issn 0006-4971, 4 p.Article

Molecular Analysis of PDGFRA and PDGFRB Genes by Rapid Single-strand Conformation Polymorphism (SSCP) in Patients with Core-binding Factor Leukaemias with KIT or FLT3 MutationTROJANI, Alessandra; BARBARA RIPAMONTI, Carla; PEZZETTI, Laura et al.Anticancer research. 2008, Vol 28, Num 5A, pp 2745-2751, issn 0250-7005, 7 p.Article

Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical studyYAIUAN ZHAO; HAGINOYA, Kazuhiro; GUILIAN SUN et al.Journal of pathology. 2003, Vol 201, Num 1, pp 149-159, issn 0022-3417, 11 p.Article

Eosinophilic myeloid disorders: new classification and novel therapeutic strategiesGOTLIB, Jason.Current opinion in hematology. 2010, Vol 17, Num 2, pp 117-124, issn 1065-6251, 8 p.Article

Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cellsTURNER, S. D; ALEXANDER, D. R.Leukemia. 2006, Vol 20, Num 4, pp 572-582, issn 0887-6924, 11 p.Article

Imatinib targets other than bcr/abl and their clinical relevance in myeloid disordersPARDANANI, Animesh; TEFFERI, Ayalew.Blood. 2004, Vol 104, Num 7, pp 1931-1939, issn 0006-4971, 9 p.Article

Five years since the discovery of FIP1L1-PDGFRA : what we have learned about the fusion and other molecularly defined eosinophiliasGOTLIB, J; COOLS, J.Leukemia. 2008, Vol 22, Num 11, pp 1999-2010, issn 0887-6924, 12 p.Article

Five years since the discovery of FIP1L1-PDGFRA : what we have learned about the fusion and other molecularly defined eosinophiliasGOTLIB, J; COOLS, J.Leukemia. 2008, Vol 22, issn 0887-6924, P41-P52, HSArticle

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disordersDAVID, Marianna; CROSS, Nicholas C. P; HUGUET, Francoise et al.Blood. 2007, Vol 109, Num 1, pp 61-64, issn 0006-4971, 4 p.Article

Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosageCAIN, Jennifer A; ZHIFU XIANG; O'NEAL, Julie et al.Blood. 2007, Vol 109, Num 9, pp 3906-3914, issn 0006-4971, 9 p.Article